Disease | paroxysmal nocturnal hemoglobinuria |
Symptom | C0040053|thrombosis |
Sentences | 11 |
PubMedID- 22133780 | Previous case reports indicate that venous thrombosis in patients with paroxysmal nocturnal hemoglobinuria is amenable to thrombolysis. |
PubMedID- 21103239 | Such associated anomalies may include arteriovenous malformations, hemangiomas, pyogenic granulomatosis, and chronic illnesses such as paroxysmal nocturnal hemoglobinuria, which is associated with venous thrombosis . |
PubMedID- 25569655 | Survival analysis in paroxysmal nocturnal hemoglobinuria: survival in patients with cerebral venous thrombosis (n = 15, present series), in patients with other thrombosis (n = 56, from the société française d’hématologie registry), and in patients without thrombosis (n = 272, from the société française d’hématologie registry). |
PubMedID- 22609136 | We report a case of paroxysmal nocturnal hemoglobinuria with renal vein thrombosis, a rare complication of this disease. |
PubMedID- 23636668 | Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a korean registry. |
PubMedID- 20433987 | thrombosis in paroxysmal nocturnal hemoglobinuria - insights into the role of complement in thrombosis. |
PubMedID- 23610373 | thrombosis in paroxysmal nocturnal hemoglobinuria. |
PubMedID- 21455865 | thrombosis in patients with paroxysmal nocturnal hemoglobinuria. |
PubMedID- 24701978 | Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumab. |
PubMedID- 21241275 | thrombosis in paroxysmal nocturnal haemoglobinuria (pnh) has been suggested to be due to several pathophysiological states: a suppressed fibrinolytic system, increased leucocyte-derived tissue factor, complement (c')-mediated damage to platelets and endothelia, or increased platelet- and endothelium-derived microparticles (mps). |
PubMedID- 22262634 | thrombosis in paroxysmal noctural hemoglobinuria: an indication for eculizumab. |
Page: 1